Literature DB >> 6286033

Ranitidine in acute upper gastrointestinal haemorrhage.

J Dawson, R Cockel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286033      PMCID: PMC1499289          DOI: 10.1136/bmj.285.6340.476

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  Hematemesis and melena; with special reference to causation and to the factors influencing the mortality from bleeding peptic ulcers.

Authors:  F A JONES
Journal:  Gastroenterology       Date:  1956-02       Impact factor: 22.682

2.  A study of the factors influencing mortality rates from gastrointestinal haemorrhage.

Authors:  R Allan; P Dykes
Journal:  Q J Med       Date:  1976-10

3.  Controlled trial of cimetidine in upper gastrointestinal haemorrhage.

Authors:  S J La Brooy; J J Misiewicz; J Edwards; P M Smith; S J Haggie; L Libman; M Sarner; J H Wyllie; J Croker; P Cotton
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

4.  H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials.

Authors:  B R Macdougall; R J Bailey; R Williams
Journal:  Lancet       Date:  1977-03-19       Impact factor: 79.321

5.  Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine.

Authors:  W Domschke; G Lux; S Domschke
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

  5 in total
  6 in total

Review 1.  Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.

Authors:  J Nash; L Lambert; M Deakin
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

2.  Pharmacokinetics of ranitidine in acute upper gastrointestinal haemorrhage.

Authors:  O Varoquaux; J M Trawale; J Doll; J Andrieu; S Grosbuis; M Pays; C Advenier
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

3.  Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.

Authors:  H S Merki; L Witzel; D Kaufman; M Kempf; J Neumann; J Röhmel; R P Walt
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

4.  Upper gastrointestinal bleeding: the trials of trials.

Authors:  M J Langman
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

Review 5.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

Review 6.  Why have controlled trials failed to demonstrate a benefit of esophagogastroduodenoscopy in acute upper gastrointestinal bleeding? A probability model analysis.

Authors:  R A Erickson; M E Glick
Journal:  Dig Dis Sci       Date:  1986-07       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.